摘要
目的探讨CT引导下经皮肝穿射频消融术(RFA)治疗肝癌的临床疗效。方法对84例肝癌患者共95个病灶进行经皮肝穿肝癌射频消融术(RFA),按病灶大小分组,用CT或MRI复查及AFP水平来评估疗效。结果术后三个月CT或MRI复查,缓解率为92%,完全缓解率为65%。各组之间的完全缓解率及缓解率的差别都有统计学意义(卡方检验:P<0.005;0.025<P<0.05)。AFP从646±757IU/L降至250±267IU/L(t检验,P<0.05)。1及2年生存率分别为93%、70%。结论RFA对于治疗肝癌具有很好的临床疗效。
Objective To observe the efficacy of radiofrequency ablation （RFA）in hepatoeellular carcinoma（HCC）.Methods Eighty-five patients with 95 turner underwent CT-guided RFA. Turners were classified by their size. The therapeutic efficacy was evaluated by enhanced CT or MRI scan and AFP level. Results CT or MRI scan at three month showed that the remission rate and the complete remission rates were 92% and 65% respectively and there were difference among groups （chi square test：P〈0.005; 0.025〈P〈0.05）. 0,025）; one and two year survival rates were 93% and 73% respectively. AFP was reduced from 646＋757IU/L to 250＋_267IU/L（t test：P〈0.05）. Conclusion RFA is very efective for the treatment of HCC.
出处
《当代医学》
2009年第5期57-59,共3页
Contemporary Medicine
